{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:54:41Z","timestamp":1780592081991,"version":"3.54.1"},"reference-count":85,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2011,9,2]],"date-time":"2011-09-02T00:00:00Z","timestamp":1314921600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Headache"],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:p>Loss of benefit of a previously effective treatment regimen, also known as tolerance, can be an important barrier to the successful preventive treatment of migraine. We undertook a systematic review of the literature to identify the prevalence and possible mechanisms of drug tolerance in migraine prophylaxis. Results demonstrate that the frequency of tolerance to prophylactic migraine treatment is unknown, but available data support an estimate that it occurs in 1\u20108% of patients receiving prophylaxis. Four broad types of tolerance were identified that are likely to be relevant to migraine prophylaxis. These are pharmacokinetic, pharmacodynamic, behavioral, and cross tolerance. The mechanisms that underlie these types of tolerance determine whether their effects can be overcome or minimized. For example, certain forms of tolerance may be affected by manipulation of environmental cues associated with drug administration, by the order in which drugs are used, and by the concomitant use of other medications. Many medications used for migraine prophylaxis exert their effects through the endogenous opioid system. The implications of this finding are explored, particularly the parallels between medication overuse headache and tolerance to migraine prophylaxis. Given the many ways in which tolerance to migraine medications may develop, in some ways it is not surprising that migraine\u2010preventive drugs stop working; it is more surprising that in many cases they do not.<\/jats:p>","DOI":"10.1111\/j.1526-4610.2011.01985.x","type":"journal-article","created":{"date-parts":[[2011,9,2]],"date-time":"2011-09-02T00:22:14Z","timestamp":1314922934000},"page":"1323-1335","source":"Crossref","is-referenced-by-count":23,"title":["Tolerance to the Beneficial Effects of Prophylactic Migraine Drugs: A Systematic Review of Causes and Mechanisms"],"prefix":"10.1111","volume":"51","author":[{"given":"Paul","family":"Rizzoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth W.","family":"Loder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,9,2]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1385\/0-89603-129-2:565"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00607.x"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh682"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2008.01131.x"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1998.3807497.x"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1999.3903190.x"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000323925.29520.e7"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2005.01.008"},{"key":"e_1_2_10_10_2","volume-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","author":"Blumenthal DK"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(86)90449-1"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-003-0013-5"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(02)00012-6"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130051056"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-8329(91)90221-H"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00652251"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(93)90267-W"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016482709120085"},{"key":"e_1_2_10_19_2","first-page":"89","volume-title":"Tolerance to the Beneficial and Adverse Effects of Antiepileptic Drugs","author":"Siegel S","year":"1986"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0149-7634(85)90037-5"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0741-8329(85)90122-3"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1037\/0033-295X.92.1.78"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nlm.2008.09.012"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1037\/0033-295X.98.3.390"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0173(95)00002-K"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90551-0"},{"key":"e_1_2_10_27_2","first-page":"7","volume-title":"Tolerance to the Beneficial and Adverse Effects of Antiepileptic Drugs","author":"Frey H","year":"1986"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90811-4"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.00994.x"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00616.x"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200721020-00005"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2009.07.014"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(95)00100-B"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1997.00550210071015"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(94)90206-2"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1989.hed2907425.x"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1985.hed2507368.x"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.26.2.121"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.36.4.684"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2010.01.001"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706315"},{"key":"e_1_2_10_42_2","first-page":"569","volume-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","author":"Gutstein HB","year":"2001"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(75)90228-9"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.50.397"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(81)90229-X"},{"key":"e_1_2_10_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2008.02.055"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.01.031"},{"key":"e_1_2_10_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00373-2"},{"key":"e_1_2_10_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(96)00489-4"},{"key":"e_1_2_10_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(05)80019-0"},{"key":"e_1_2_10_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00200-3"},{"key":"e_1_2_10_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200305000-00037"},{"key":"e_1_2_10_53_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-199804000-00028"},{"key":"e_1_2_10_54_2","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e3181ae5f13"},{"key":"e_1_2_10_55_2","unstructured":"RozenTD.Doxycycline for treatment resistant new daily persistent headache.2008;70(Suppl.1):A348."},{"key":"e_1_2_10_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00849-9"},{"key":"e_1_2_10_57_2","first-page":"475","article-title":"Role of nitric oxide in the development of tolerance to diazepam\u2010induced motor impairment in mice","volume":"60","author":"Talarek S","year":"2008","journal-title":"Pharmacol Rep"},{"key":"e_1_2_10_58_2","doi-asserted-by":"publisher","DOI":"10.1080\/00207450902776192"},{"key":"e_1_2_10_59_2","doi-asserted-by":"publisher","DOI":"10.3923\/pjbs.2009.798.803"},{"key":"e_1_2_10_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02494.x"},{"key":"e_1_2_10_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1991.tb05626.x"},{"key":"e_1_2_10_62_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31820d8af2"},{"key":"e_1_2_10_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(94)00405-8"},{"key":"e_1_2_10_64_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1999.7343"},{"key":"e_1_2_10_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(02)01035-3"},{"key":"e_1_2_10_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2003.34803.x"},{"key":"e_1_2_10_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(92)90069-R"},{"key":"e_1_2_10_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(96)00062-7"},{"key":"e_1_2_10_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4886(85)90026-3"},{"key":"e_1_2_10_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(92)90070-V"},{"key":"e_1_2_10_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(92)90068-Q"},{"key":"e_1_2_10_72_2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0022-3565(25)12118-6","article-title":"Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil","volume":"275","author":"Rundfeldt C","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_10_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(87)90010-4"},{"key":"e_1_2_10_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(76)90015-7"},{"key":"e_1_2_10_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(83)90263-7"},{"key":"e_1_2_10_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(96)00199-3"},{"key":"e_1_2_10_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(92)90071-M"},{"key":"e_1_2_10_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(93)90037-8"},{"key":"e_1_2_10_79_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2001.26800.x"},{"key":"e_1_2_10_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(90)90238-2"},{"key":"e_1_2_10_81_2","first-page":"393","article-title":"The effect of gabapentin on antinociceptive action of analgesics","volume":"61","author":"Pakulska W","year":"2004","journal-title":"Acta Pol Pharm"},{"key":"e_1_2_10_82_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2005.00889.x"},{"key":"e_1_2_10_83_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000134653.35587.24"},{"key":"e_1_2_10_84_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-008-0983-5"},{"key":"e_1_2_10_85_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181f9618c"},{"issue":"1","key":"e_1_2_10_86_2","first-page":"9","article-title":"The International Classification of Headache Disorders: 2nd edition","volume":"24","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","journal-title":"Cephalalgia"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1526-4610.2011.01985.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1526-4610.2011.01985.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:30:22Z","timestamp":1762079422000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/j.1526-4610.2011.01985.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":85,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.1111\/j.1526-4610.2011.01985.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1526-4610.2011.01985.x","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}